HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Fibrinolysis in the treatment of the amaurosis fugax: a case report].

Abstract
The authors report a case of amaurosis fugax treated first by systemic fibrinolysis and then by antiplatelet treatment. A 47-year-old suffering from transient amaurosis due to recurrent occlusion of retinal arterial branches improved after treatment and showed no recurrence. This protocol appears effective in cases of probable embolus in a young patient with no contraindications and when flow is not reestablished (amaurosis fugax), or when the required 6-hour time delay is respected.
AuthorsL Derieux, J-L Guyomard, A Catier, T Derieux, A Le Callonnec, C Juveneton, J-F Charlin
JournalJournal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 26 Issue 5 Pg. 507-9 (May 2003) ISSN: 0181-5512 [Print] France
Vernacular TitleFibrinolyse dans le traitement de l'amaurosis fugax. A propos d'un cas.
PMID12819612 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
Topics
  • Amaurosis Fugax (drug therapy)
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Retinal Vessels (pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: